Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Submitted by
admin
on November 2, 2017 - 9:56am
Source:
Endpoints
News Tags:
Agios Pharmaceuticals
ASH
FDA
IDH1
ivosidenib
Headline:
Agios spotlights promising data for IDH1 drug, putting it on the path to FDA submission
Do Not Allow Advertisers to Use My Personal information
